Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function

BACKGROUND: Chronic kidney disease (CKD) is an important risk factor for mortality from COVID-19. Remdesivir has been shown to shorten time to recovery in patients with severe COVID-19. However, exclusion of patients with severe kidney function impairment in clinical trials has led to concerns about...

Descripción completa

Detalles Bibliográficos
Autores principales: Seethapathy, Rituvanthikaa, Wang, Qiyu, Zhao, Sophia, Strohbehn, Ian A., Long, Joshua D., Dinulos, James E., Harden, Destiny, Kadiyala, Vinay B., Moreno, Daiana, Sise, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970064/
https://www.ncbi.nlm.nih.gov/pubmed/36848366
http://dx.doi.org/10.1371/journal.pone.0279765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970064/
https://www.ncbi.nlm.nih.gov/pubmed/36848366
http://dx.doi.org/10.1371/journal.pone.0279765

Ejemplares similares